Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...

The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could ...

Patients can inject Zepbound and Wegovy under their skin with a click ... who could benefit from treatment but are afraid of needles. Th pill could also tap into new markets in countries that ...

If clinically effective, a successful oral treatment could theoretically threaten injected incumbents such as Ozempic and Wegovy. Most people would probably prefer a pill to a needle. Indeed ...